- ►annals.org RA Rubin, TE Kowalski, M Khandelwal, PF … - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To explain the rationale supporting the use of ursodiol ( ... Cited by 53 - Related articles - All 3 versions
- ►bmj.com [PDF] S Saksena, RK Tandon - British Medical Journal, 1997 - pmj.bmj.com Summary Ursodeoxycholic acid is a dihy- droxy bile acid with a rapidly expanding
spectrum of usage in acute and chronic liver diseases. The various mechanisms
ofaction of this hydrophilic bile acid in- clude direct cytoprotection, ... Cited by 17 - Related articles - BL Direct - All 6 versions
R Tsumita, N Sugiura, A Abe, M Ebara, H … - Journal of gastroenterology and hepatology, 2001 - ingentaconnect.com Extracorporeal shock-wave lithotripsy was first per- formed clinically in 1986
by Sauerbruch et al. in Germany. 2 In Japan, ESWL was introduced in 1987 and has
since been widely used as a safe and effective pro- cedure for the ... Cited by 14 - Related articles - BL Direct - All 4 versions
R Poupon, RE Poupon - Pharmacology and Therapeutics, 1995 - Elsevier Cholestasis can be defined as the manifestation of defective bile acid transport
from the liver to the intestine. Most chronic cholestatic conditions can
progress towards cirrhosis. At this stage, liver transplantation is the ... Cited by 53 - Related articles - BL Direct - All 4 versions
G Rudolph, R Endele, M Senn, A Stiehl - Hepatology, 1993 - interscience.wiley.com Treatment of patients with cholestatic liver diseases with ursodeoxycholic acid
has been shown to have beneficial effects that may be related to a shift in the
balance between hydrophilic and hydrophobic bile acids in favor of ... Cited by 32 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] A Darzi, JG Geraghty, NN Williams, SS … - Annals of The Royal College of Surgeons of England, 1994 - pubmedcentral.nih.gov Key words: Extracorporeal shock wave lithotripsy; Laparoscopic cholecystectomy ... The recent introduction of laparoscopic cholecystectomy (LAPC) has
revolutionised the surgical treatment of gall- stone disease. However, it ... Cited by 7 - Related articles - BL Direct - All 3 versions
R Fried, A Gratwohl, G Stalder - Bile acids in gastroenterology: basic and clinical …, 1995 - books.google.com 43 Ursodeoxycholic acid for the treatment of refractory chronic graft-
versus-host-disease of the liver R. FRIED, A. GRATWOHL and G. STALDER
INTRODUCTION Chronic graft-versus-host-disease of the liver (GVHD) occurs ... Cited by 71 - Related articles - BL Direct - All 5 versions
GH Shimokura, JM McGill, T Schlenker, JG … - Gastroenterology, 1995 - Elsevier : Ursodeoxycholate (UDC) stimulates a bicarbonate-rich choleresis, but the
cellular mechanisms involved are not fully established. Because ductular
secretion also increases biliary HCO 3 − concentration, the purpose of ... Cited by 40 - Related articles - BL Direct - All 6 versions
AF Hofmann - Scandinavian Journal of Gastroenterology, 1994 - informahealthcare.com A. F. HOFMANN Dept. of Medicine, University of California, San Diego, USA ...
Hofmann AF. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J
Gastroenterol ... The pharmacokinetics, metabolism, as well as the ... Cited by 103 - Related articles - BL Direct - All 4 versions
RE Poupon, K Ouguerram, Y Chrétien, C … - Hepatology, 1993 - interscience.wiley.com We have previously shown in a 2-yr controlled trial that hypercholesterolemia,
frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to
15 mg daily). To further investigate this effect, we analyzed the influence ... Cited by 46 - Related articles - BL Direct - All 4 versions
